title: Renal protection in diabetes.
authors.affiliation: Utah Valley Regional Medical Center, Provo, Utah, USA.
authors.forename: Judd D
authors.initials: JD
authors.lastname: Hunter
authors.forename: Patricia K
authors.initials: PK
authors.lastname: Ravert
authors.forename: Jane H
authors.initials: JH
authors.lastname: Lassetter
authors.forename: Mary
authors.initials: M
authors.lastname: Williams
mesh_terms: D000450:Aldosterone / Q000097:blood; D057911:Angiotensin Receptor Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003928:Diabetic Nephropathies / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D007668:Kidney / Q000187:drug effects; D011188:Potassium / Q000097:blood; D011507:Proteinuria / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D051437:Renal Insufficiency / Q000517:prevention & control*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000450:Aldosterone; D011188:Potassium